Immunomic Therapeutics, Inc.

Industry

  • Biotechnology
    • Drug Discovery Technologies
    • Large Molecule
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
      • Macromolecule
See more in Biomedtracker

Latest on Immunomic Therapeutics, Inc.

Scrip

Deal Watch: Lilly Teams With Regor On Metabolic Disorders

 
• By Joseph Haas and Dexter Jie Yan

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Doubles Down On Metabolic Disorde

Scrip

Deal Watch: Gain To Test Enzyme-Enhancement Tech In Cancer With Zentalis

 
• By Joseph Haas and Ian Haydock

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Gain, Zentalis Hope To Find Protein Mis

Scrip

Asia Deal Watch: Betta Will Bring Two Agenus Oncology Candidates To Its Market Area

 
• By Ian Haydock, Jung Won Shin, Anju Ghangurde, and Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Betta Gains China-Plus Rights To Two Ag

Scrip

Finance Watch: Erasca Raises $200m As VC Mega-Rounds Continue

 
• By Mandy Jackson

April has been an astonishing month for biopharmaceutical venture capital investment, with billions of dollars in new financings and new VC funds. About $1bn in new venture rounds were announced durin